Femoral frACturEs and COVID-19.

NCT04657510 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 140

Last updated 2020-12-08

No results posted yet for this study

Summary

Retrospective cohort study comparing the early prognosis after surgically-treated proximal femur fragility fractures in patients affected and not affected by COVID-19.

Conditions

  • Covid19
  • Femur Fracture
  • Fragility Fracture

Interventions

OTHER

COVID-19

Patients affected versus not affected by COVID-19, with the same starting condition (proximal femur fracture)

Sponsors & Collaborators

  • I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio

    lead OTHER

Principal Investigators

  • Giuseppe M Peretti, MD · IRCCS Istituto Ortopedico Galeazzi

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-14
Primary Completion
2020-12-01
Completion
2020-12-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04657510 on ClinicalTrials.gov